Loading ...

Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

prostate-specific membrane antigen-targeted irinotecan-containing nanoparticles

Based on

1 Patents
2014 Most recent source

Composition

1

PLGA-mPEG5K

Type Polymer
Formula
Role core
2

poly(lactide-co-glycolic acid)-polyethyleneglycol-S,S-2[3-][5-amino-1-carboxypentyl]-ureido]-pentanedioic acid

PLGA-mPEG5K-LIG
Type Polymer
Formula
Role layer
3

(S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]-indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate

irinotecan Camptosa CPT
Type Single Compound
Formula C33H38N4O6
Role loaded material

Properties

Applications

Area Application Nanomaterial Variant Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Biological effects

Biological system Test details Nanomaterial Variant Source
human prostatic carcinoma PSMA-overexpressing LNCaP cells

More information available to subscribers only.

Or, view sample content

Preparation

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial